Next Article in Journal
Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
Next Article in Special Issue
Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation
Previous Article in Journal
Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
Previous Article in Special Issue
Dexamethasone-Loaded Radially Mesoporous Silica Nanoparticles for Sustained Anti-Inflammatory Effects in Rheumatoid Arthritis
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(9), 1763; https://doi.org/10.3390/pharmaceutics14091763
Action Date Notes Link
article xml file uploaded 24 August 2022 13:59 CEST Original file -
article xml uploaded. 24 August 2022 13:59 CEST Update https://www.mdpi.com/1999-4923/14/9/1763/xml
article pdf uploaded. 24 August 2022 13:59 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1763/pdf
article html file updated 24 August 2022 14:01 CEST Original file -
article html file updated 24 August 2022 21:40 CEST Update https://www.mdpi.com/1999-4923/14/9/1763/html
Back to TopTop